Cancer Research UK - Cancer survival improves in England
Cancer survival has steadily climbed over the last seven years, according to official figures(link is external) from the Office for National Statistics (ONS).
Researchers followed patients who were diagnosed with one of the 24 commonest types of cancer between 2010 and 2014.
Overall, both 1 year and 5 year survival has increased since 2009.
More than 8 out of 10 people affected by cancers of the breast (in women), prostate, testis and thyroid gland, and for Hodgkin lymphoma and melanoma of the skin, survive their disease for at least five years, as medical advances, public awareness campaigns and other public health measures have improved the way doctors diagnose and treat these diseases.
As more people are surviving cancer, there is a need to develop kinder treatments, to help make sure patients have the best quality of life during and after their cancer journey.
For the first time, the figures also included predicted 10 year survival numbers. More than 8 in 10 people diagnosed with melanoma skin cancer or breast cancer are predicted to survive at least ten years or more.
But the picture is very different for other cancer types. Fewer than 15% of people with lung, pancreatic, oesophageal cancers or brain tumours are expected to be alive ten years after their diagnosis.
For cancers that occur in both sexes, survival tends to be higher in women. But there are exceptions - bladder cancer, for example, has a higher five-year survival (57%) in men compared to women (48%).
Commenting on the new figures, Dr Rebecca Smittenaar, Cancer Research UK’s statistics manager, said: “Cancer survival is improving and has doubled over the last 40 years. For a number of cancers, including breast and skin cancer, more than eight out of 10 people will survive their disease. Research has led to better treatments, new drugs, more accurate tests, earlier diagnosis and screening programmes – giving patients a better chance of survival.
But while more people are beating cancer, experts claim more still needs to be done to challenge its position as the number one cause of death in England and Wales.
Dr Smittenaar added, “Far too many people still die from the disease. Improving survival is a priority in England’s cancer strategy. We want to see the strategy put into action across the country, so that no matter where you live you have the best possible chance of surviving cancer.
“Survival remains low for some cancers, including lung, pancreatic, oesophageal cancer and brain tumours, partly because they tend to be diagnosed at a later stage when they're much harder to treat. To turn this around Cancer Research UK has increased investment in these cancers and is carrying out vital research to help save more lives.”
Office for National Statistics bulletin(link is external)
Latest News from
Age UK comments on Dispatches investigation into Bupa care homes20/06/2017 12:35:00
Age UK has commented on the Channel 4 Dispatches programme from Monday 19 June 2017, 'Bupa Care Homes Undercover'.
Care system 'buckling' says Age UK as major care homes investigation launches15/06/2017 10:35:00
A recent study into the quality of care homes which has sparked a much wider legal investigation has been called 'a manifestation of our buckling social care system' by Age UK.
Diabetes UK - Brits failing to meet the recommended daily allowance of fruit and veg13/06/2017 09:35:00
A new survey* commissioned by Diabetes UK to promote its Food you love healthy eating campaign in Diabetes Week (Sunday 11 June to Saturday 17 June), has found that 66 per cent of adults eat three or fewer portions of fruit and/or vegetables a day – well below the recommended five portions - and 46 per cent won’t eat any fruit at least three days a week.
CRUK - Combining immunotherapies could benefit some aggressive breast cancers09/06/2017 10:15:00
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
CRUK - Two clinical trials show promise with different targeted drugs for lung cancer07/06/2017 14:10:00
Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available, according to unpublished clinical trials.
CRUK - New chemotherapy approach offers breast cancer patients a better quality of life07/06/2017 12:10:00
The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative regimen called CMF, when given following epirubicin.
CRUK - Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent06/06/2017 10:35:00
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate cancer presented at the 2017 ASCO Annual Meeting in Chicago and published in the New England Journal of Medicine on Saturday.
British Red Cross - Manchester attack – What happens after05/06/2017 16:15:00
An edition of the BRC’s Newsthink encourages young people to consider ways that the public helped each other after the explosion. It also explores the role of practical help and emotional support during and after an emergency.